Sowah LA, Smeaton L, Brates I, Bhattacharya D, et al. Perspectives on Adherence from the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach with 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment. Clin Infect Dis 2023 Jan 24:ciad034. doi: 10.1093.
PMID: 36694361